Shares of Intellia Therapeutics, Inc. NTLA were down 4.5% on Jun 26 after it announced that its current chief financial officer (CFO), Glenn Goddard, is stepping down from his role effective Jun 30, ...
Source LinkShares of Intellia Therapeutics, Inc. NTLA were down 4.5% on Jun 26 after it announced that its current chief financial officer (CFO), Glenn Goddard, is stepping down from his role effective Jun 30, ...
Source Link
Comments